G. Mark

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

V. A. Stewart, S. D. de Vlas, Joe D. Cohen, 2009, PloS one.